home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences
Search  -  prev / next
 
 

Utilizing State-of-the-Art DEL Technology to Discover Compounds that Hit Challenging Therapeutic Targets

 
  October 25, 2022  
     
 
Xtalks, online
2022 -12-01


DNA-encoded small molecule libraries (DELs) created using combinatorial chemistry and synthetic oligonucleotides are being successfully applied to drug discovery projects across the pharmaceutical industry. There have been many recent advances in DEL technology with the promise of helping to deliver ever more efficacious and beneficial small molecule-based tools and therapies.
 
In this webinar, the featured speaker will review the use of state-of-the-art DEL technology to uncover compounds that modulate challenging therapeutic targets, including the following applications:
 

Identification of hits to target in complex biological systems
Targeted protein degradation
Discovery of irreversible covalent binders
Identifying binders to nucleic acid targets and
Enhanced hit identification of DEL screen output using machine learning
 
 
Register for this webinar to learn about leading advances in DEL technology.
 
 
Organized by: Xtalks
Invited Speakers: John (JP) Guilinger, PhD, Director, Lead Discovery and Biochemistry, X-Chem
 
Deadline for Abstracts: 2022 -12-01
 
Registration: Free registration
E-mail: ajuurinen@xtalks.com
 
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2022 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.